BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16317267)

  • 1. Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: implications for stereotactic body radiotherapy.
    Kelsey CR; Schefter T; Nash SR; Russ P; Barón AE; Zeng C; Gaspar LE
    Am J Clin Oncol; 2005 Dec; 28(6):576-80. PubMed ID: 16317267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation.
    Chen HY; Ma XM; Ye M; Hou YL; Hu B; Bai YR
    J Radiat Res; 2013 Sep; 54(5):938-42. PubMed ID: 23616629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microinvasion in hepatocellular carcinoma: predictive factor and application for definition of clinical target volume for radiotherapy.
    Yan H; Liu L; Wang D; Xu J; Sun Y; Liang S; Huang Y; Hao X; Lin N; Xu X
    World J Surg Oncol; 2024 May; 22(1):125. PubMed ID: 38720338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
    Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
    AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation.
    Mastrocostas K; Fischer S; Munoz-Schuffenegger P; Jang HJ; Dawson LA; Liu ZA; Sapisochin G; Kim TK
    Abdom Radiol (NY); 2021 Apr; 46(4):1572-1585. PubMed ID: 33074426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of discrepancies between radiological and pathological size of hepatocellular carcinoma masses.
    Tian F; Wu JX; Rong WQ; Wang LM; Wu F; Yu WB; An SL; Liu FQ; Feng L; Liu YH
    Asian Pac J Cancer Prev; 2014; 15(21):9487-94. PubMed ID: 25422244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT and MRI in target delineation in primary hepatocellular carcinoma.
    Chen HY; Hou YL; Ma XM; Xie HY; Ye M; Bai YR
    Cancer Radiother; 2013 Dec; 17(8):750-4. PubMed ID: 24262499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation.
    Peterson MS; Baron RL; Marsh JW; Oliver JH; Confer SR; Hunt LE
    Radiology; 2000 Dec; 217(3):743-9. PubMed ID: 11110938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy.
    Ehman EC; Umetsu SE; Ohliger MA; Fidelman N; Ferrell LD; Yeh BM; Yee J; Hope TA
    Abdom Radiol (NY); 2016 Nov; 41(11):2161-2168. PubMed ID: 27484789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Size discrepancy between sonographic and computed tomographic/magnetic resonance imaging measurement of hepatocellular carcinoma: the necessity of tumor size measurement standardization.
    Cha MJ; Lee MW; Cha DI; Kim JH; Rhim H; Cho YK; Kim YJ; Choi D; Kim YS; Lim HK
    J Ultrasound Med; 2013 Oct; 32(10):1703-9. PubMed ID: 24065250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in chronic hepatitis C in the absence of advanced fibrosis or cirrhosis.
    Lewis S; Roayaie S; Ward SC; Shyknevsky I; Jibara G; Taouli B
    AJR Am J Roentgenol; 2013 Jun; 200(6):W610-6. PubMed ID: 23701091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic Response of Hepatocellular Carcinoma Treated with Yttrium-90 Glass Microsphere Radiation Segmentectomy Prior to Liver Transplantation: A Validation Study.
    Toskich B; Vidal LL; Olson MT; Lewis JT; LeGout JD; Sella DM; Montazeri SA; Devcic Z; Lewis AR; Frey GT; Ritchie CA; Paz-Fumagalli R; Croome KP; Patel TC
    J Vasc Interv Radiol; 2021 Apr; 32(4):518-526.e1. PubMed ID: 33551304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphasic spiral computed tomography for detection of hepatocellular carcinoma before resection or orthotopic liver transplantation.
    Lopez Hänninen E; Vogl TJ; Bechstein WO; Guckelberger O; Neuhaus P; Lobeck H; Felix R
    Invest Radiol; 1998 Apr; 33(4):216-21. PubMed ID: 9556746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-staging of hepatocellular carcinoma via external-beam radiotherapy with subsequent liver transplantation: a case report.
    Wigg A; Hon K; Mosel L; Sladden N; Palumbo K
    Liver Transpl; 2013 Oct; 19(10):1119-24. PubMed ID: 23894122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma.
    Sandroussi C; Dawson LA; Lee M; Guindi M; Fischer S; Ghanekar A; Cattral MS; McGilvray ID; Levy GA; Renner E; Greig PD; Grant DR
    Transpl Int; 2010 Mar; 23(3):299-306. PubMed ID: 19843294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.